{"doi":"10.1016/j.ejim.2022.12.020","title":"Treatment efficacy of fecal microbiota-based live biotherapeutics (RBX2660) for the prevention of recurring Clostridioides difficile infection","abstract":null,"journal":"European Journal of Internal Medicine","year":2023,"id":644000,"datarank":0.20794415416798362,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.0,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":864385,"name":"Muhammad Afzal","orcid":"0000-0002-5785-6067","position":1,"is_corresponding":false},{"id":1675956,"name":"Khola Ilyas","orcid":null,"position":2,"is_corresponding":false},{"id":1133476,"name":"Azza Sarfraz","orcid":"0000-0001-8206-5745","position":3,"is_corresponding":false},{"id":1443552,"name":"Zouina Sarfraz","orcid":"0000-0002-5132-7455","position":4,"is_corresponding":false},{"id":1675955,"name":"Qurat ul Ain Javed","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Treatment efficacy of fecal microbiota-based live biotherapeutics (RBX2660) for the prevention of recurring Clostridioides difficile infection","abstract":null,"is_dataset_classified":null,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36581474","pmcid":null,"openalex_id":"https://openalex.org/W4312213981","authors":[],"funders":[],"total_grants":0,"fwci":0.2896,"citation_percentile":0.55680826,"influential_citations":0,"citation_trend":[{"year":2023,"count":2},{"year":2024,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0953620522004484?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0953620522004484?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.ejim.2022.12.020","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36581474","host_type":"repository"}],"fields_of_study":["Clostridium difficile and Clostridium perfringens research","Gut microbiota and health","Gastrointestinal motility and disorders","Humans","Feces","Clostridium Infections","Treatment Outcome","Microbiota","Recurrence"],"mesh_terms":["Clostridium Infections","Feces","Humans","Recurrence","Treatment Outcome","Microbiota"],"keywords":["Clostridioides","Medicine","Fecal bacteriotherapy","Clostridium difficile","Feces","Microbiology","Internal medicine","Antibiotics"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-08T20:28:04.821221Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}